Half of kids who needed epinephrine didn't get it before trip to the emergency room

July 12, 2017

Anyone suffering a severe allergic reaction (anaphylaxis) should receive epinephrine as quickly as possible. A new study showed that even kids who were prescribed an epinephrine auto injector didn't receive the life-saving medication when they needed it.

The study in Annals of Allergy, Asthma and Immunology, the scientific publication of the American College of Allergy, Asthma and Immunology (ACAAI) examined 408 patient records for children seen in an emergency department (ED) or urgent care (UC) setting for . The records showed fewer than half the children received prior to arriving at the ED or UC even though approximately 65 percent had a known history of anaphylaxis, and 47 percent had been prescribed epinephrine.

"We found kids who had a at home were less likely to receive epinephrine than kids who had a reaction at school," says Melissa Robinson, DO, ACAAI member and lead author of the study. "Treatment with epinephrine is often delayed or avoided by parents and caregivers. And sometimes antihistamines are used even though they are not an appropriate treatment."

Once they arrived at the ED/UC, only 50 percent of all patients received epinephrine. That number includes even those that got epinephrine before arrival. Because the study examined only if kids received epinephrine upon arrival at the ED/UC, there is no information on the reasons epinephrine wasn't given. The study did determine that children who received epinephrine prior to arrival were less likely to be treated with epinephrine once they arrived. Kids who received epinephrine prior to arrival were also more likely to be sent home compared to those who didn't.

"Allergists want parents, caregivers and emergency responders to know epinephrine should always be the first line of defense when treating anaphylaxis," says allergist David Stukus, member of the ACAAI Public Relations Committee and co-author of the study. "Our study found that only two-thirds of those who had an epinephrine prescription had their auto injector available at the time of their allergic reaction. It's vital to keep your epinephrine with you if you suffer from any sort of severe allergy. Anaphylaxis symptoms occur suddenly and can progress quickly. Always have a second dose with you and, when in doubt, administer it too. Anaphylaxis can be deadly if left untreated."

Anyone seen for anaphylaxis in the ED/UC needs to be referred to an allergist for a follow up visit. Allergists provide the most comprehensive follow-up care and guidance for severe allergic reactions.

Explore further: Even if severe allergic reaction is in doubt, epinephrine should be used

Related Stories

Even if severe allergic reaction is in doubt, epinephrine should be used

August 6, 2015
There are times when emergency physicians can't be 100 percent sure a person is suffering from a severe allergic reaction, known as anaphylaxis, and may hesitate to use epinephrine. A new article says when in doubt - administer ...

Study shows second severe allergic reaction can occur hours after first

July 7, 2015
Parents of kids with severe allergies know how scary a severe allergic reaction (anaphylaxis) is. New research offers clues as to why some kids can have a second, related reaction hours later - and what to do about it.

If you are having a severe allergic reaction, you need epinephrine first and fast

December 2, 2014
If you are one of the millions of Americans who experiences a severe allergic reaction to food, latex or an insect sting, you should know the first line of defense in combating the reaction is epinephrine. Unfortunately, ...

School staff know more than they think they do about treating anaphylaxis

November 11, 2016
A study being presented at the American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting found only 18 percent of non-nurse school staff surveyed felt very confident in their ability to recognize ...

Emergency supplies of epinephrine in schools save lives

November 7, 2014
Millions of children across the country need emergency epinephrine at school because they could suffer a severe, potentially life-threatening allergic reaction (anaphylaxis) to food or an insect sting. As schools across the ...

Needed: an 'action plan' for kids prone to severe allergic reactions

February 13, 2017
(HealthDay)—When kids are at risk of severe allergic reactions, all their caregivers should have a written action plan and epinephrine auto-injectors readily available, according to new reports from the American Academy ...

Recommended for you

Gene immunotherapy protects against multiple sclerosis in mice

September 21, 2017
A potent and long-lasting gene immunotherapy approach prevents and reverses symptoms of multiple sclerosis in mice, according to a study published September 21st in the journal Molecular Therapy. Multiple sclerosis is an ...

New academic study reveals true extent of the link between hard water and eczema

September 21, 2017
Hard water damages our protective skin barrier and could contribute to the development of eczema, a new study has shown.

Exposure to pet and pest allergens during infancy linked to reduced asthma risk

September 19, 2017
Children exposed to high indoor levels of pet or pest allergens during infancy have a lower risk of developing asthma by 7 years of age, new research supported by the National Institutes of Health reveals. The findings, published ...

Cholesterol-like molecules switch off the engine in cancer-targeting 'Natural Killer' cells

September 18, 2017
Scientists have just discovered how the engine that powers cancer-killing cells functions. Crucially, their research also highlights how that engine is fuelled and that cholesterol-like molecules, called oxysterols, act as ...

MicroRNA helps cancer evade immune system

September 18, 2017
The immune system automatically destroys dysfunctional cells such as cancer cells, but cancerous tumors often survive nonetheless. A new study by Salk scientists shows one method by which fast-growing tumors evade anti-tumor ...

'Exciting' discovery on path to develop new type of vaccine to treat global viruses

September 15, 2017
Scientists at the University of Southampton have made a significant discovery in efforts to develop a vaccine against Zika, dengue and Hepatitis C viruses that affect millions of people around the world.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.